← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vaccinex, Inc.
Rochester, NY
$5,043,051
Total funding
10
Grants
Funding mix
By agency
NIH$5,043,051 · 10
By mechanism
R43$4,134,391 · 9
R44$908,660 · 1
Investigators at Vaccinex, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Human Monoclonal Antibodies for Bioterrorism Defense$717,652
R43 · FY2005 · AI
Human Monoclonal Antibodies for Bioterrorism Defense$641,026
R43 · FY2004 · AI
C35: A Target for Bladder and Breast Cancer Therapy$472,605
R44 · FY2001 · CA
C35: A Target for Bladder and Breast Cancer Therapy$436,055
R44 · FY2002 · CA
New Target Antigens for Prostate Cancer Immunotherapy$303,809
R43 · FY2004 · CA
New Target Antigens for Prostate Cancer Immunotherapy$295,926
R43 · FY2005 · CA
NEW TARGET ANTIGENS FOR PROSTATE CANCER VACCINES$238,912
R43 · FY2001 · CA
NEW TARGET ANTIGENS FOR PROSTATE CANCER VACCINES$238,912
R43 · FY2000 · CA
Functional Identification of Cancer Regulators$234,188
R43 · FY2005 · CA
Genetic Selection System to Clone Osteogenic Regulators$225,774
R43 · FY2003 · AG
Monoclonal Antibody Therapy to Combat Osteoporosis$217,632
R43 · FY2004 · AG
A METHOD TO IDENTIFY UPSTREAM REGULATORS OF ONCOGENES$216,700
R43 · FY2004 · CA
A METHOD TO IDENTIFY UPSTREAM REGULATORS OF ONCOGENES$216,700
R43 · FY2003 · CA
Genetic Selection System to Clone Osteogenic Regulators$208,300
R43 · FY2002 · AG
Functional Identification of Cancer Regulators$178,861
R43 · FY2004 · CA
GENE EXPRESSION AND IMMUNOGENS OF UROEPITHELIAL TUMORS$100,000
R43 · FY2000 · CA
Genetic Selection to Clone Chondrogenic Regulators$99,999
R43 · FY2001 · AR